Oragenics receives NYSE American deficiency notice
Oragenics (OGEN) received a deficiency letter from NYSE American LLC stating it is not in compliance with continued listing standards.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.